Brookdale Senior Living (BKD) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Underwent major organizational transformation, including new leadership, hiring a COO, and aligning teams for improved accountability and performance.
Achieved strong Q1 2026 results with 8.2% year-over-year RevPAR growth, 280 bps occupancy gain, and industry recognition for 294 communities.
Ongoing portfolio optimization with 10 communities sold in 2026 for over $100 million, targeting $200 million in dispositions, and managed portfolio reduced to seven communities.
Net loss narrowed to $6.9 million from $65 million year-over-year; Adjusted EBITDA rose 5.6% to $131.1 million.
Operates 568 senior living communities in 41 states, serving about 51,000 residents as of March 31, 2026.
Financial highlights
Q1 2026 consolidated occupancy rose 280 bps year-over-year to 82.1%; same-community occupancy up 170 bps to 82.7%.
Resident fees declined 7.1% year-over-year to $722.5 million due to asset sales, but same community RevPAR rose 5.5% and RevPOR increased 4.5%.
Adjusted EBITDA increased 5.6% year-over-year to $131.1 million, despite a 14% decline in unit count.
Facility operating expenses decreased 8.2% year-over-year, reflecting asset dispositions.
Net loss improved by $58.1 million year-over-year, primarily due to lower depreciation, amortization, and lease expenses.
Outlook and guidance
Reaffirmed 2026 guidance: 8%-9% RevPAR growth and adjusted EBITDA of $502 million-$516 million.
Expects mid-teens adjusted EBITDA growth through 2028, with leverage projected to fall below 6x by end of 2028.
G&A expense guidance for 2026 reduced to $157 million, with most savings realized in the second half.
April occupancy trends and strong move-in volume support confidence in achieving full-year targets.
Expects to fund liquidity needs for at least the next 12 months through cash, operations, credit facility, and asset sales.
Latest events from Brookdale Senior Living
- Occupancy and EBITDA are set to rise as strategic changes and strong demand drive growth.BKD
Bank of America Global Healthcare Conference 202613 May 2026 - Director elections, executive pay, and auditor ratification headline the 2026 annual meeting.BKD
Proxy filing30 Apr 2026 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.BKD
Proxy filing30 Apr 2026 - Record 2025 EBITDA and occupancy growth set the stage for robust 2026 performance.BKD
Q4 202510 Apr 2026 - Operational focus, targeted CapEx, and market-driven M&A support growth amid strong demand.BKD
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Q2 saw 20% Adjusted EBITDA growth, higher occupancy, but a wider net loss on higher costs.BKD
Q2 20241 Feb 2026 - 2026 targets $502–$516M Adjusted EBITDA and 8–9% RevPAR growth, led by operational transformation.BKD
Investor Day 202630 Jan 2026 - Q3 2024 delivered 15% EBITDA growth, higher occupancy, and $610M in acquisitions pending.BKD
Q3 202415 Jan 2026 - Strategic acquisitions, strong occupancy, and HealthPlus expansion drive positive 2025 outlook.BKD
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026